Dr. Lacouture is the Director of the Oncodermatology Program at Memorial Sloan Kettering Cancer Center. He is the Founder of SERIES (Skin and Eye Reactions to Inhibitors of EGFR and Kinases) Clinic, an interdisciplinary effort comprising patient care, education, and research. He is also Co-Chair of the Skin Toxicity Study Group of the Multinational Association of Supportive Care in Cancer. Dr. Lacouture focuses on the recognition and management of the side effects affecting the skin, hair, and nails of cancer patients and survivors as a consequence of chemotherapy and radiation therapy. His research also encompasses exploring dermatologic side effects resulting from cancer treatment and exploring new skin treatments that do not affect the effectiveness of anticancer drugs.